| Literature DB >> 34847880 |
Dominic T Mathis1,2, Joshua Schmidli3, Michael T Hirschmann3,4, Felix Amsler5, Johann Henckel6, Harry Hothi6, Alister Hart6.
Abstract
BACKGROUND: With the Persona® knee system a new polyethylene formulation incorporating vitamin-E which aims to reduce oxidation and maintain wear resistance was introduced. Although in-vitro studies have demonstrated positive effects of the vitamin-E antioxidants on UHMWPE, no retrieval study has looked at polyethylene damage of this system yet. It was the aim to investigate the in-vivo performance of this new design, by comparing it with its predecessor in retrieval analysis.Entities:
Keywords: Polyethylene; Polyethylene surface damage; Retrieval analysis; Surface roughness; Total knee arthroplasty
Mesh:
Substances:
Year: 2021 PMID: 34847880 PMCID: PMC8630848 DOI: 10.1186/s12891-021-04898-y
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Patient demographics
| Case number | Gender | Age, yrs | Time to revision, yrs | Reason(s) for revision | Design, Type | Revision surgeon |
|---|---|---|---|---|---|---|
| 1 | F | 51.3 | 0.4 | Patellofemoral, stiffness, malalignment | NexGen®, PS | Surgeon 1 |
| 2 | M | 50.9 | 3.0 | Instability | Persona®, PS | Surgeon 1 |
| 3 | F | 71.1 | 1.0 | Instability, patellofemoral | Persona®, CR | Surgeon 1 |
| 4 | F | 76.6 | 9.0 | Instability | NexGen®, PS | Surgeon 2 |
| 5 | F | 61.8 | 5.9 | Periprosthetic fracture | NexGen®, CR | Surgeon 2 |
| 6 | F | 71.3 | 5.9 | Instability | NexGen®, CR | Surgeon 2 |
| 7 | F | 67.3 | 7.8 | Malalignment | NexGen®, CR | Surgeon 2 |
| 8 | M | 70.6 | 1.6 | Instability | Persona®, PS | Surgeon 1 |
| 9 | F | 67.8 | 3.5 | Instability, stiffness | Persona®, CR | Surgeon 1 |
| 10 | F | 69.2 | 1.4 | Instability, patellofemoral | Persona®, PS | Surgeon 1 |
| 11 | F | 66.3 | 14.8 | Progression of OA | NexGen®, PS | Surgeon 2 |
| 12 | F | 72.2 | 1.5 | Instability, patellofemoral | Persona®, PS | Surgeon 1 |
| 13 | F | 52.4 | 0.9 | Stiffness | NexGen®, CR | Surgeon 2 |
| 14 | F | 69.3 | 1.9 | Instability | NexGen®, PS | Surgeon 2 |
| 15 | F | 79.6 | 9.7 | Instability | NexGen®, CR | Surgeon 2 |
| 16 | M | 69.3 | 5.8 | Instability | NexGen®, CR | Surgeon 2 |
| 17 | F | 84.2 | 10.1 | Instability | NexGen®, CR | Surgeon 2 |
| 18 | F | 79.8 | 14.1 | Instability | NexGen®, CR | Surgeon 2 |
| 19 | F | 72.8 | 13.1 | Instability | NexGen®, CR | Surgeon 2 |
| 20 | F | 80.2 | 1.2 | Stiffness | NexGen®, CR | Surgeon 2 |
| 21 | M | 70.5 | 3.2 | Instability, malalignment | Persona®, CR | Surgeon 1 |
| 22 | F | 58.3 | 18.1 | Instability | NexGen®, PS | Surgeon 2 |
| 23 | F | 66.0 | 2.2 | Instability | Persona®, CR | Surgeon 1 |
SD standard deviation, OA osteoarthritis, PS posterior stabilized, CR cruciate retaining
Patient demographics by implant type
| Design, type | Gender (F:M) | Age at revision, mean and SD (yrs) | Time to revision, mean and SD (yrs) | Reason(s) for revision |
|---|---|---|---|---|
| Persona®, total | 5:3 | 67.3 (± 6.9) | 2.2 (± 0.94) | Instability ( |
| Persona®, CR | 3:1 | 68.9 (± 2.4) | 2.5 (± 1.1) | Instability ( |
| Persona®, PS | 2:2 | 65.7 (± 10) | 1.9 (0.7) | Instability ( |
| NexGen®, total | 14:1 | 69.4 (± 10.1) | 7.9 (± 5.5) | Instability (n = 9, 60.0%); stiffness ( |
| NexGen®, CR | 9:1 | 71.9 (± 9.7) | 7.4 (± 4.4) | Instability ( |
| NexGen®, PS | 5:0 | 64.4 (± 9.8) | 8.9 (± 7.7) | Instability ( |
SD standard deviation, OA osteoarthritis, PS posterior stabilized, CR cruciate retaining, the percentages totalled > 100% because some knees had more than one reason for revision recorded
Fig. 1Examples of the two knee implant designs involved in the study: A-C predecessor knee system NexGen®; D-F novel anatomic knee system Persona® A CoCr fixed bearing tibial tray, B CoCr femoral shield, C polyethylene tibial insert posterior-stabilized, D CoCr fixed bearing tibial tray, E CoCr femoral shield, F polyethylene tibial insert posterior-stabilized
Fig. 2Flow chart showing the study design; PE, polyethylene; TKA, total knee arthroplasty
Fig. 3Surface division according to the Hood score
Mean values and standard deviations (SD) of surface roughness values and hood scores of all implants investigated; N of all revision reasons
| Implant type | Total ( | NexGen® ( | Persona® ( | Comparison | Comparison – corrected for time to revision | ||
|---|---|---|---|---|---|---|---|
| Surface roughness (Ra) and Hood Score | Mean, SD | Mean, SD | Mean, SD | R2 | P | R2 | P |
| Tibial lateral Ra | 0.14 (+/−0.07) | 0.18 (+/−0.04) | 0.07 (+/−0.04) | 0.68 | .000 | 0.65 | .000 |
| Tibial medial Ra | 0.15 (+/− 0.08) | 0.2 (+/− 0.05) | 0.06 (+/− 0.01) | 0.77 | .000 | 0.71 | .000 |
| Tibial lateral & medial Ra | 0.15 (+/−0.07) | 0.19 (+/− 0.04) | 0.06 (+/− 0.03) | 0.78 | .000 | 0.75 | .000 |
| Femoral lateral Ra | 0.14 (+/− 0.03) | 0.15 (+/− 0.04) | 0.13 (+/− 0.01) | 0.09 | .166 | 0.20 | .046 |
| Femoral medial Ra | 0.14 (+/− 0.03) | 0.14 (+/− 0.03) | 0.14 (+/− 0.03) | 0.01 | .745 | 0.06 | .291 |
| Femoral lateral & medial Ra | 0.14 (+/− 0.02) | 0.14 (+/− 0.03) | 0.14 (+/− 0.02) | 0.02 | .484 | 0.20 | .046 |
| Hood Score articulating lateral | 22.2 (+/−4.8) | 22.1 (+/−4.7) | 22.7 (+/−5.7) | 0.00 | .805 | 0.04 | .387 |
| Hood Score articulating central | 12.8 (+/−3.1) | 13.2 (+/−3.0) | 11.8 (+/−3.7) | 0.04 | .381 | 0.00 | .833 |
| Hood Score articulating medial | 23.9 (+/−7.2) | 23.6 (+/−8.2) | 24.7 (+/−4.6) | 0.00 | .769 | 0.01 | .617 |
| Hood Score articulating total | 59 (+/−10.2) | 58.9 (+/−9.4) | 59.2 (+/−11.0) | 0.00 | .953 | 0.03 | .475 |
| Hood Score backside lateral | 22.4 (+/−4.5) | 22.9 (+/− 4.6) | 21.3 (+/− 4.4) | 0.03 | .490 | 0.04 | .410 |
| Hood Score backside central | 10.9 (+/−3) | 11.0 (+/−3.3) | 10.5 (+/−2.2) | 0.01 | .740 | 0.02 | .590 |
| Hood Score backside medial | 21.2 (+/−5.7) | 22.3 (+/−5.8) | 18.3 (+/−4.7) | 0.11 | .149 | 0.14 | .105 |
| Hood Score backside total | 54.5 (+/−10.9) | 56.2 (+/−11.3) | 50.2 (+/−9.2) | 0.07 | .261 | 0.10 | .183 |
| Hood Score lateral total | 44.7 (+/−7.2) | 44.9 (+/−6.3) | 44.0 (+/−9.7) | 0.00 | .795 | 0.00 | .956 |
| Hood Score medial total | 45.1 (+/−10.5) | 45.9 (+/−11.9) | 43.0 (+/− 6.3) | 0.02 | .577 | 0.01 | .616 |
| Hood Score overall total | 113.4 (+/−17.1) | 115.1 (+/−17.1) | 109.3 (+/−18.0) | 0.02 | .502 | 0.01 | .674 |
| Reason for revision | N (%) | N (%) | N (%) | R2 | P | R2 | P |
| Instability | 17 (73.9) | 9 (60.0) | 8 (100) | 0.19 | .039 | 0.29 | .014 |
| Malalignment | 3 (13.0) | 2 (13.0) | 1 (12.5) | 0.00 | .957 | 0.00 | .795 |
| Patellofemoral | 4 (17.4) | 1 (7.0) | 3 (37.5) | 0.15 | .068 | 0.03 | .463 |
| Stiffness | 4 (17.4) | 3 (20.0) | 1 (12.5) | 0.01 | .669 | 0.11 | .153 |
| Others (periprosthetic fracture, progression OA) | 2 (8.7) | 2 (13) | 0 (0) | 0.05 | .301 | 0.01 | .689 |
Comparison between the two implant designs using R2. P-values < 0.05 were considered statistically significant
Fig. 4Example of surface roughness analysis performed using a contact profilometer
Fig. 5Graphs showing the comparison of overall, articulating and backside surface Hood score between NexGen® and Persona® tibial inserts (fixed bearings)
Fig. 6Graphs showing the comparison of articulating surface roughness (Ra) of femoral and tibial components between NexGen® and Persona® implants
Pearson correlation between implant design, time to revision, reason for revision, surface roughness and Hood score. *** p < 0.001, ** p < 0.01, * p < 0.05
| Pearson correlation | Implant type (Persona® - NexGen®) | Time to revision | Reason for revision | Roughness | Hood score | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Instability | Malalignment | Patellofemoral | Stiffness | Tibial total | Femoral total | Articulating total | Backside | Overall total | ||||
| Implant type (Persona® - NexGen®) | 1*** | −0.53** | 0.43* | −0.01 | 0.39 | −0.09 | −0.88*** | −0.15 | 0.01 | −0.26 | −0.16 | |
| Time to revision | −0.53** | 1 | 0.09 | − 0.16 | − 0.43* | − 0.4 | 0.34 | − 0.39 | 0.26 | − 0.03 | 0.14 | |
| Reason for revision | Instability | 0.43** | 0.09 | 1 | −0.36 | 0.01 | −0.51* | − 0.53** | − 0.25 | 0.2 | 0.23 | 0.26 |
| Malalignment | −0.01 | −0.16 | − 0.36 | 1 | 0.16 | 0.16 | −0.04 | 0.01 | −0.22 | −0.62** | − 0.52* | |
| Patellofemoral | 0.39 | −0.43* | 0.01 | 0.16 | 1 | 0.09 | −0.31 | 0.13 | −0.6** | −0.43 | − 0.63** | |
| Stiffness | −0.09 | −0.4 | − 0.51* | 0.16 | 0.09 | 1 | 0.18 | 0.52* | −0.06 | 0.14 | 0.05 | |
| Roughness | Tibial total | −0.88*** | 0.34 | −0.53** | −0.04 | − 0.31 | 0.18 | 1 | 0.06 | −0.11 | 0.26 | 0.1 |
| Femoral total | −0.15 | −0.39 | − 0.25 | 0.01 | 0.13 | 0.52* | −0.06 | 1 | −0.07 | 0.32 | 0.16 | |
| Hood score | Articulating total | 0.01 | 0.26 | 0.2 | −0.22 | −0.6** | −0.06 | − 0.11 | −0.07 | 1 | 0.32 | 0.8*** |
| Backside | −0.26 | −0.03 | 0.23 | −0.62** | − 0.43 | 0.14 | 0.26 | 0.32 | 0.32 | 1 | 0.82*** | |
| Overall total | −0.16 | 0.14 | 0.26 | −0.52* | −0.63** | 0.05 | 0.1 | 0.16 | 0.8*** | 0.82*** | 1 | |